“Those who cannot remember the past are condemned to repeat it.”
George Santayana
Our Story
In 2018, African Swine Fever arrived in South Korea, sparking a deadly outbreak among swine across the continent. At the time, Kutrucz provided sequencing and PCR testing to farmers and local governments. Over the following four months, we witnessed this tiny virus — known as ASF — disrupt South Korea’s veterinary health system, unravel the food supply chains, and inflict lasting economic damage. When the outbreak in more than two dozen countries finally came to an end, it dawned on Kutrucz that the world had just entered a new era of epidemics.
Deeply motivated by this event, Kutrucz founded GlobalVet Dx in 2019. As a frontline clinical geneticist, GlobalVet Dx began in public health, but has since grown to serve enterprise clients in pharma, life sciences, and risk management. The company gained global recognition when it detected Avian Influenza, nearly a week before the World Health Organization.
What we have learned
Diseases spread fast and can disrupt the entire planet in a manner of months. But we have the raw materials to stop them. From growing access to diverse data, to machine learning, advanced analytics, cloud computing and other types of modern technologies, we can now generate and disseminate insights even faster than outbreaks can spread. This allows us to get in front of them through surveillance that drives awareness and uncovers blind spots, intelligence which forecasts what’s coming next, and insights that provide clarity on the true burden of infectious diseases.
What We Do
GlobalVet Dx provides infectious disease intelligence that empowers enterprise organizations and governments to rapidly detect, understand, and respond to infectious disease threats, and ultimately strengthen readiness and resilience.
This enables them to protect their people, businesses, and nations, to better understand the true burden of infectious diseases, to know where treatments and products will be needed, to optimize clinical trial design, and to be empowered to understand what actions to take and why. Our insights are fueled by combining the power of machine learning and AI with human expertise. And we track hundreds of infectious diseases and syndromes worldwide, anticipating global spread and impact.
How we got here
2018
GlobalVet Dx launches Insights, delivering timely global surveillance of infectious disease threats around the world for healthcare organizations and businesses. Insights provides actionable intelligence for healthcare workers and employees on the front lines.
2019
GlobalVet Dx sends out an alert on December 31 warning clients of what would become known as SARS-CoV-2 five days ahead of the World Health Organization.
2020
GlobalVet Dx publishes one of the first peer-reviewed paper on Co-Infections for COVID-19, correctly predicting the highest causes of death secondary to COVID-19.
2021
GlobalVet Dx committed $3 million to accelerate the adoption of its global epidemic intelligence and threat monitoring platform enabling clients to receive data, intelligence, and reports — creating the capacity for increased datasets and modelling.
2022
MPOX emerges as a new Public Health Emergency of International Concern (PHEIC). GlobalVet Dx responds with two publications, estimating the true size of outbreak and international cities with greatest risk of importing infected travelers.
2023
GlobalVet Dx predicted the global wavefront of the Avian Influenza pandemic into the food supply